BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27837696)

  • 1. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A.
    Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N
    Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
    Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
    Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
    Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
    Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
    Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
    Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
    Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
    Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsense-mediated mRNA decay was demonstrated in two hypofibrinogenemias caused by heterozygous nonsense mutations of FGG, Shizuoka III and Kanazawa II.
    Soya K; Takezawa Y; Okumura N; Terasawa F
    Thromb Res; 2013 Oct; 132(4):465-70. PubMed ID: 24011387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro transcription of compound heterozygous hypofibrinogenemia Matsumoto IX; first identification of FGB IVS6 deletion of 4 nucleotides and FGG IVS3-2A>G causing abnormal RNA splicing.
    Terasawa F; Kamijyo Y; Fujihara N; Yamauchi K; Kumagai T; Honda T; Shigematsu S; Okumura N
    Clin Chim Acta; 2010 Sep; 411(17-18):1325-9. PubMed ID: 20580695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.
    Taira C; Matsuda K; Arai S; Sugano M; Uehara T; Okumura N
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio.
    Uitte de Willige S; Rietveld IM; De Visser MC; Vos HL; Bertina RM
    J Thromb Haemost; 2007 Jun; 5(6):1243-9. PubMed ID: 17403086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
    Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A
    Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.
    Asselta R; Robusto M; Braidotti P; Peyvandi F; Nastasio S; D'Antiga L; Perisic VN; Maggiore G; Caccia S; Duga S
    J Thromb Haemost; 2015 Aug; 13(8):1459-67. PubMed ID: 26039544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
    Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
    Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel fibrinogen γ chain frameshift deletion (c.637delT) in a patient with hypodysfibrinogenemia associated with thrombosis.
    Ivaškevičius V; Thomas A; Biswas A; Ensikat H; Schmitt U; Horneff S; Pavlova A; Poetzsch B; Oldenburg J
    Hamostaseologie; 2015; 35 Suppl 1():S27-31. PubMed ID: 26540127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of congenital fibrinogen disorders.
    Lebreton A; Casini A
    Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense mutation (FGG c.1168G > T) in the gamma chain of fibrinogen causing congenital hypodysfibrinogenemia with bleeding phenotype.
    Xu N; Zheng L; Dai Z; Zhu J; Xie P; Yang S; Chen F
    Hereditas; 2024 Jan; 161(1):4. PubMed ID: 38233949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.
    Yoda M; Kaido T; Kamijo T; Taira C; Higuchi Y; Arai S; Okumura N
    Int J Hematol; 2021 Sep; 114(3):325-333. PubMed ID: 34117991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hypofibrinogenemia associated with novel homozygous fibrinogen Aα and heterozygous Bβ chain mutations.
    Castaman G; Rimoldi V; Giacomelli SH; Duga S
    Thromb Res; 2015 Jul; 136(1):144-7. PubMed ID: 25981141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice.
    Walton BL; Getz TM; Bergmeier W; Lin FC; Uitte de Willige S; Wolberg AS
    J Thromb Haemost; 2014 May; 12(5):680-9. PubMed ID: 24916154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.